1SXPSCHOTT Pharma AG & Co. KGaA
17.24EUR-5.27%Mkt Cap: 2.60B EURP/E: 18.15Last update: 2026-06-01

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…

Indicators:|

Key Statistics

Company
Market Cap2.60B EUR
Enterprise Value3.02B EUR
Revenue (TTM)991.22M EUR
Gross Profit332.46M EUR
Net Income (TTM)146.45M EUR
Revenue/Share6.613 EUR
Last Price17.24 EUR
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees4.8K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A3ENQ51
Valuation
P/E (Trailing)18.15
P/E (Forward)16.91
PEG
EV/EBITDA11.78
EV/Revenue3.04
P/S2.77
P/B2.91
EPS (TTM)0.95
EPS (Forward)1.08
52W Range
12.6226% of range30.25
52W High30.25 EUR
52W Low12.62 EUR
Profitability
Gross Margin33.71%
Oper. Margin15.95%
EBITDA Margin25.85%
Profit Margin14.85%
ROE16.42%
ROA9.16%
Growth
Revenue Growth-1.50%
Earnings Growth-16.00%
Cash Flow & Leverage
Operating CF179.92M EUR
CapEx (TTM)144.76M EUR
FCF Margin-3.30%
FCF Yield-1.26%
Net Debt274.03M EUR
Net Debt/EBITDA1.07
Balance Sheet
Debt/Equity0.09
Current Ratio1.59
Quick Ratio0.69
Book Value/Sh6.256 EUR
Cash/Share0.1850 EUR
Dividends
Fwd Div Rate0.1800 EUR
Trail. Div Rate0.1800 EUR
Div. Yield1.00%
5Y Avg Yield
Payout Ratio18.95%
Ex-Div DateFeb 4, 2026
Pay Date
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)19.43 EUR
Target Range13.00 EUR25.90 EUR
# Analysts12
Ownership
Shares Out.150.61M
Float34.64M
Insiders77.00%
Institutions19.33%
Technical
SMA 5015.00 (+15.0%)
SMA 20016.92 (+1.9%)
Beta0.89
S&P 52W Chg27.70%
Avg Vol (30d)87.32K
Avg Vol (10d)65.72K
Technical Indicators
RSI (14)79.4
MACD0.7691
MACD Signal0.6112
MACD Hist.+0.1579
BB Upper18.17 EUR
BB Middle16.29 EUR
BB Lower14.40 EUR
BB Width23.19%
ATR (14)0.5495 EUR
Vol Ratio (20d)2.85x